v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended 91 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Income Statement [Abstract]          
Sales    $ 177,500 $ 177,459 $ 177,500 $ 957,799
Operating Expenses          
Selling, general and administrative 797,195 585,205 2,521,695 2,504,110 17,267,669
Research and development 895,669 562,425 2,364,686 2,285,637 15,365,276
Total operating expenses 1,692,864 1,147,630 4,886,381 4,789,746 32,632,945
Interest expense, net 95,001 75,034 251,978 179,029 767,566
Net loss during the development stage $ (1,787,865) $ (1,045,164) $ (4,960,900) $ (4,791,275) $ (32,442,712)
Basic and diluted loss per share $ (0.01) $ (0.01) $ (0.03) $ (0.07)   
Weighted average number of common shares outstanding 149,057,350 80,655,861 149,057,350 73,164,046